1.Loss of IκB kinase β promotes myofibroblast transformation and senescence through activation of the ROS-TGFβ autocrine loop.
Liang CHEN ; Zhimin PENG ; Qinghang MENG ; Maureen MONGAN ; Jingcai WANG ; Maureen SARTOR ; Jing CHEN ; Liang NIU ; Mario MEDVEDOVIC ; Winston KAO ; Ying XIA
Protein & Cell 2016;7(5):338-350
Using forward and reverse genetics and global gene expression analyses, we explored the crosstalk between the IκB kinase β (IKKβ) and the transforming growth factor β (TGFβ) signaling pathways. We show that in vitro ablation of Ikkβ in fibroblasts led to progressive ROS accumulation and TGFβ activation, and ultimately accelerated cell migration, fibroblast-myofibroblast transformation and senescence. Mechanistically, the basal IKKβ activity was required for anti-oxidant gene expression and redox homeostasis. Lacking this activity, IKKβ-null cells showed ROS accumulation and activation of stress-sensitive transcription factor AP-1/c-Jun. AP-1/c-Jun activation led to up-regulation of the Tgfβ2 promoter, which in turn further potentiated intracellular ROS through the induction of NADPH oxidase (NOX). These data suggest that by blocking the autocrine amplification of a ROS-TGFβ loop IKKβ plays a crucial role in the prevention of fibroblast-myofibroblast transformation and senescence.
Adenoviridae
;
genetics
;
Animals
;
Autocrine Communication
;
physiology
;
Cell Line
;
Cell Movement
;
Cellular Senescence
;
Genetic Vectors
;
genetics
;
metabolism
;
I-kappa B Kinase
;
deficiency
;
genetics
;
metabolism
;
JNK Mitogen-Activated Protein Kinases
;
metabolism
;
Mice
;
Myofibroblasts
;
cytology
;
metabolism
;
NADPH Oxidases
;
metabolism
;
Oxidative Stress
;
Promoter Regions, Genetic
;
Reactive Oxygen Species
;
metabolism
;
Signal Transduction
;
Superoxide Dismutase
;
genetics
;
metabolism
;
Transcription Factor AP-1
;
metabolism
;
Transforming Growth Factor beta
;
genetics
;
metabolism
;
Up-Regulation
2.New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.
Hua CHENG ; Tong REN ; Shao-cong SUN
Protein & Cell 2012;3(8):581-589
Human T cell leukemia virus type 1 (HTLV-1), an etiological factor that causes adult T cell leukemia and lymphoma (ATL), infects over 20 million people worldwide. About 1 million of HTLV-1-infected patients develop ATL, a highly aggressive non-Hodgkin's lymphoma without an effective therapy. The pX region of the HTLV-1 viral genome encodes an oncogenic protein, Tax, which plays a central role in transforming CD4+ T lymphocytes by deregulating oncogenic signaling pathways and promoting cell cycle progression. Expression of Tax following viral entry is critical for promoting survival and proliferation of human T cells and is required for initiation of oncogenesis. Tax exhibits diverse functions in host cells, and this oncoprotein primarily targets IκB kinase complex in the cytoplasm, resulting in persistent activation of NF-κB and upregulation of its responsive gene expressions that are crucial for T cell survival and cell cycle progression. We here review recent advances for the pathological roles of Tax in modulating IκB kinase activity. We also discuss our recent observation that Tax connects the IκB kinase complex to autophagy pathways. Understanding Tax-mediated pathogenesis will provide insights into development of new therapeutics in controlling HTLV-1-associated diseases.
Autophagy
;
CD4-Positive T-Lymphocytes
;
metabolism
;
virology
;
Cell Cycle
;
Cell Transformation, Neoplastic
;
genetics
;
Gene Expression Regulation, Neoplastic
;
Gene Products, tax
;
genetics
;
metabolism
;
Human T-lymphotropic virus 1
;
physiology
;
Humans
;
I-kappa B Kinase
;
genetics
;
metabolism
;
Leukemia-Lymphoma, Adult T-Cell
;
genetics
;
metabolism
;
virology
;
Membrane Microdomains
;
metabolism
;
virology
;
NF-kappa B
;
genetics
;
metabolism
;
Protein Binding
;
Signal Transduction
;
genetics
3.The Role of NF-kappaB in Colon Cancer.
The Korean Journal of Gastroenterology 2011;57(1):3-7
Colon cancer is the 3rd common malignancy and 4th common cause of cancer death in Korea. Recent studies have shown that abnormal inflammatory response plays a critical role in colon carcinogenesis. A striking example of connection between inflammation and cancer is NF-kappaB, in which key regulator of inflammation and immune response is associated with target for colon cancer treatment. Constitutive NF-kappaB expression in colon cancer is 40-80% in vivo as well as in vitro, and the inactivation of IKKbeta subunit can reduce tumor multiplicity. The possible mechanisms by which NF-kappaB can contribute to colon carcinogenesis include the activator of antiapoptotic gene expression, enhanced cell survival and proliferation, regulation of angiogenesis and promotion of metastasis of cancer cells. Recent insights into the role of NF-kappaB involved in colon cancer development as well as their relevance as therapeutic targets are herein discussed.
Colonic Neoplasms/*etiology/metabolism
;
Humans
;
I-kappa B Kinase/metabolism/physiology
;
Inflammation
;
NF-kappa B/metabolism/*physiology
4.Altered nuclear factor-kappaB inducing kinase expression in insulin-resistant mice.
Lei SU ; Ling-Ling XIU ; Guo-Hong WEI ; Xing ZHONG ; Yuan-Yuan LIU ; Xiao-Pei CAO ; Yan-Bing LI ; Hai-Peng XIAO
Chinese Medical Journal 2011;124(22):3646-3651
<b>BACKGROUNDb>Insulin resistance is an underlying feature of both type 2 diabetes and metabolic syndrome. Currently, it is unclear whether nuclear factor (NF)-κB inducing kinase (NIK) plays a role in the development of insulin resistance. The present in vivo study investigated the roles of NIK and IκB kinase α (IKKα) in obesity-induced insulin resistance using animal models.
<b>METHODSb>NIK expression was evaluated by Western blotting in male Lep(ob) mice and C57BL/6J mice fed a high-fat diet (HFD) (45% fat). After metformin and sulfasalazine treatment, NIK expression was investigated during the improvement of insulin resistance.
<b>RESULTSb>NIK was increased by about 1-fold in the renal tissues of Lep(ob) mice and C57BL/6J mice fed a HFD for 12 weeks. After 1 and 3 weeks of high-fat feeding, we observed an almost 50% decrease in NIK and IKKα expression in the liver and renal tissues of C57BL/6J mice. NIK expression was significantly lower in the liver and renal tissues of HFD-fed mice that were treated with insulin sensitizers, metformin and sulfasalazine. However, IKKα expression was increased after metformin treatment in both tissues.
<b>CONCLUSIONb>These results suggest a possible role of NIK in the liver and renal tissues of insulin-resistant mice.
Animals ; Blotting, Western ; Body Weight ; physiology ; Fasting ; blood ; Glucose Tolerance Test ; I-kappa B Kinase ; metabolism ; Insulin ; blood ; Insulin Resistance ; physiology ; Kidney ; metabolism ; Liver ; metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Obese ; Protein-Serine-Threonine Kinases ; metabolism
5.Research progress of the biological characteristics of IkappaB kinase and its inhibitors.
Jian-Yue XUE ; Bin ZHOU ; Da-Yong ZHANG ; Xiao-Ming WU
Acta Pharmaceutica Sinica 2011;46(3):253-260
The NF-kappaB pathway regulates the expression of over 150 target genes, e.g., cytokines, chemokines, leukocyte adhesion molecules and inducible effector enzymes. Consequently, it plays a crucial role in innate and adaptive immune responses, inflammatory response, stress responses, apoptosis and so on. IkappaB kinase (IKK) is the key of this pathway, and it owns a special structure which consists of catalytic subunit and regulatory subunit. Naturally, the activation of IKK needs the interaction of the two subunits and phosphorylation by its upstream kinases. Actually, there are two methods of activation of the NF-kappaB pathway, and both of the methods need the IKK complex. Given to the crucial role of IKK, researchers have isolated and synthesized amounts of IKK inhibitors, and these provide a great convenience to develop novel anti-inflammatory and anti-tumor drugs.
Animals
;
Anti-Inflammatory Agents
;
pharmacology
;
Antineoplastic Agents
;
pharmacology
;
Enzyme Activation
;
Enzyme Inhibitors
;
metabolism
;
pharmacology
;
Humans
;
I-kappa B Kinase
;
antagonists & inhibitors
;
chemistry
;
metabolism
;
physiology
;
NF-kappa B
;
metabolism
;
Phosphorylation
;
Signal Transduction
6.Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Wen ZHANG ; Xuan ZHANG ; Xiao-Li WU ; Liu-Sheng HE ; Xiao-Feng ZENG ; Amrie C CRAMMER ; Peter E LIPSKY
Chinese Medical Sciences Journal 2010;25(1):1-12
<b>OBJECTIVEb>To investigate the role of TNF receptor-associated factor 2 (TRAF-2) and TRAF6 in CD40-induced nuclear factor-kappaB (NF-kappaB) signaling pathway and whether CD40 signaling requires TRAF2.
<b>METHODSb>Human B cell lines were transfected with plasmids expressing wild type TRAF2 or dominant negative TRAF2, TRAF2-shRNA, or TRAF6-shRNA. The activation of NF-kappaB was detected by Western blot, kinase assay, transfactor enzyme-linked immunosorbent assay (ELISA), and fluorescence resonance energy transfer (FRET). Analysis of the role of TRAF-2 and TRAF-6 in CD40-mediated NF-kappaB activity was examined following stimulation with recombinant CD154.
<b>RESULTSb>TRAF2 induced activity of IkappaB-kinases (IKKalpha, IKKi/epsilon), phosphorylation of IkappaBalpha, as well as nuclear translocation and phosphorylation of p65/RelA. In contrast, TRAF6 strongly induced NF-kappaB activation and nuclear translocation of p65 as well as p50 and c-Rel. Engagement of CD154-induced nuclear translocation of p65 was inhibited by a TRAF6-shRNA, but conversely was enhanced by a TRAF2-shRNA. Examination of direct interactions between CD40 and TRAFs by FRET documented that both TRAF2 and TRAF6 directly interacted with CD40. However, the two TRAFs competed for CD40 binding.
<b>CONCLUSIONSb>These results indicate that TRAF2 can signal in human B cells, but it is not essential for CD40-mediated NF-kappaB activation. Moreover, TRAF2 can compete with TRAF6 for CD40 binding, and thereby limit the capacity of CD40 engagement to induce NF-kappaB activation.
Animals ; B-Lymphocytes ; cytology ; physiology ; CD40 Antigens ; metabolism ; Cell Line ; Extracellular Signal-Regulated MAP Kinases ; metabolism ; Fluorescence Resonance Energy Transfer ; Humans ; I-kappa B Kinase ; metabolism ; NF-kappa B ; genetics ; metabolism ; Proto-Oncogene Proteins c-fos ; metabolism ; Signal Transduction ; physiology ; TNF Receptor-Associated Factor 2 ; genetics ; metabolism ; TNF Receptor-Associated Factor 6 ; genetics ; metabolism ; Transcription Factor RelA ; metabolism ; p38 Mitogen-Activated Protein Kinases ; metabolism
7.Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I Interferon.
Kyung Hyun BOO ; Joo Sung YANG
Yonsei Medical Journal 2010;51(1):9-17
Intrinsic cellular defenses are non-specific antiviral activities by recognizing pathogen-associated molecular patterns (PAMPs). Toll-like receptors (TLRs), one of the pathogen recognize receptor (PRR), sense various microbial ligands. Especially, TLR2, TLR3, TLR4, TLR7, TLR8 and TLR9 recognize viral ligands such as glycoprotein, single- or double-stranded RNA and CpG nucleotides. The binding of viral ligands to TLRs transmits its signal to Toll/interleukin-1 receptor (TIR) to activate transcription factors via signal transduction pathway. Through activation of transcription factors, such as interferon regulatory factor-3, 5, and 7 (IRF-3, 5, 7) or nuclear factor-kappaB (NF-kappaB), type I interferons are induced, and antiviral proteins such as myxovirus-resistance protein (Mx) GTPase, RNA-dependent Protein Kinase (PKR), ribonuclease L (RNase L), Oligo-adenylate Synthetase (OAS) and Interferon Stimulated Gene (ISG) are further expressed. These antiviral proteins play an important role of antiviral resistancy against several viral pathogens in infected cells and further activate innate immune responses.
Animals
;
GTP-Binding Proteins/metabolism
;
Humans
;
Interferon Regulatory Factors/metabolism
;
Interferon Type I/*metabolism/physiology
;
Models, Biological
;
NF-kappa B/metabolism
;
Toll-Like Receptors/metabolism
;
Virus Diseases/*immunology/*metabolism/virology
;
eIF-2 Kinase/metabolism
8.Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
Sang Eun KIM ; Tran Thi THUY ; Ji Hyun LEE ; Jai Youl RO ; Young An BAE ; Yoon KONG ; Jee Yin AHN ; Dong Soon LEE ; Yeon Mock OH ; Sang Do LEE ; Yun Song LEE
Experimental & Molecular Medicine 2009;41(4):277-287
Matrix metalloproteinase-9 (MMP-9) may play an important role in emphysematous change in chronic obstructive pulmonary disease (COPD), one of the leading causes of mortality and morbidity worldwide. We previously reported that simvastatin, an inhibitor of HMG-CoA reductase, attenuates emphysematous change and MMP-9 induction in the lungs of rats exposed to cigarette smoke. However, it remained uncertain how cigarette smoke induced MMP-9 and how simvastatin inhibited cigarette smoke-induced MMP-9 expression in alveolar macrophages (AMs), a major source of MMP-9 in the lungs of COPD patients. Presently, we examined the related signaling for MMP-9 induction and the inhibitory mechanism of simvastatin on MMP-9 induction in AMs exposed to cigarette smoke extract (CSE). In isolated rat AMs, CSE induced MMP-9 expression and phosphorylation of ERK and Akt. A chemical inhibitor of MEK1/2 or PI3K reduced phosphorylation of ERK or Akt, respectively, and also inhibited CSE-mediated MMP-9 induction. Simvastatin reduced CSE-mediated MMP-9 induction, and simvastatin-mediated inhibition was reversed by farnesyl pyrophosphate (FPP) or geranylgeranyl pyrophosphate (GGPP). Similar to simvastatin, inhibition of FPP transferase or GGPP transferase suppressed CSE-mediated MMP-9 induction. Simvastatin attenuated CSE-mediated activation of RAS and phosphorylation of ERK, Akt, p65, IkappaB, and nuclear AP-1 or NF-kappaB activity. Taken together, these results suggest that simvastatin may inhibit CSE-mediated MMP-9 induction, primarily by blocking prenylation of RAS in the signaling pathways, in which Raf-MEK-ERK, PI3K/Akt, AP-1, and IkappaB-NF-kappaB are involved.
1-Phosphatidylinositol 3-Kinase/metabolism
;
Alkyl and Aryl Transferases/metabolism
;
Animals
;
Anticholesteremic Agents/pharmacology
;
Cells, Cultured
;
Enzyme Inhibitors/metabolism/pharmacology
;
Extracellular Signal-Regulated MAP Kinases/metabolism
;
Gene Expression Regulation, Enzymologic/*drug effects
;
I-kappa B Kinase/antagonists & inhibitors/metabolism
;
Macrophages, Alveolar/cytology/*drug effects/*enzymology
;
Matrix Metalloproteinase 9/genetics/*metabolism
;
Mitogen-Activated Protein Kinase Kinases/metabolism
;
Polyisoprenyl Phosphates/metabolism
;
Proto-Oncogene Proteins c-akt/metabolism
;
Rats
;
Sesquiterpenes/metabolism
;
Signal Transduction/physiology
;
Simvastatin/*pharmacology
;
Smoke/*adverse effects
;
*Tobacco/adverse effects/chemistry
9.CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
International Journal of Oral Science 2009;1(3):105-118
<b>AIMb>To determine how SDF-1 alpha/CXCR4 activates nuclear factor-kappa B (NF-kappaB) and promotes oral squamous cell carcinoma (OSCC) invasion.
<b>METHODOLOGYb>A lentivirus-based knockdown approach was utilized to deplete gene expression. NF-kappaB activation was evaluated by Western blot analysis and electrophoretic mobility shift (EMSA).
<b>RESULTSb>We show that the activation of NF-kappaB by CXCR4 occurs through the Carma3/Bcl10/Malt1 (CBM) complex in OSCC. We found that loss of components of the CBM complex in HNSCC can inhibit SDF-1 alpha induced phosphorylation and degradation of IkappaBalpha, while TNF alpha induced IKK activation remains unchanged. Further, we identified a role for novel and atypical, but not classical, PKCs in activating IKK through CXCR4. Importantly, inhibition of the CBM complex leads to a significant decrease in SDF-1 alpha mediated invasion of OSCC.
<b>CONCLUSIONb>The CBM complex plays a critical role in CXCR4-induced NF-kappaB activation in OSCC. Targeting molecular components of the NF-kappaB signaling pathway may provide an important therapeutic opportunity in controlling the progression and metastasis of OSCC mediated by SDF-1 alpha.
Adaptor Proteins, Signal Transducing ; antagonists & inhibitors ; physiology ; B-Cell CLL-Lymphoma 10 Protein ; CARD Signaling Adaptor Proteins ; antagonists & inhibitors ; physiology ; Carcinoma, Squamous Cell ; pathology ; Caspase Inhibitors ; Caspases ; physiology ; Cell Line, Tumor ; Chemokine CXCL12 ; antagonists & inhibitors ; physiology ; Enzyme Activation ; drug effects ; Gene Silencing ; Genetic Vectors ; genetics ; Humans ; I-kappa B Kinase ; drug effects ; I-kappa B Proteins ; metabolism ; Isoenzymes ; antagonists & inhibitors ; Lentivirus ; genetics ; Membrane Proteins ; antagonists & inhibitors ; physiology ; Mouth Neoplasms ; pathology ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein ; NF-KappaB Inhibitor alpha ; NF-kappa B ; antagonists & inhibitors ; physiology ; Neoplasm Invasiveness ; Neoplasm Proteins ; antagonists & inhibitors ; physiology ; Phosphorylation ; Plasmids ; genetics ; Protein Kinase C ; antagonists & inhibitors ; Receptors, CXCR4 ; physiology ; Tumor Necrosis Factor-alpha ; pharmacology
10.Cysteine-179 of I kappa B kinase beta plays a critical role in enzyme activation by promoting phosphorylation of activation loop serines.
Mi Sun BYUN ; Jin CHOI ; Dae Myung JUE
Experimental & Molecular Medicine 2006;38(5):546-552
I kappa B kinase beta (IKK beta) subunit of IKK complex is essential for the activation of NF-kappa B in response to various proinflammatory signals. Cys-179 in the activation loop of IKK beta is known to be the target site for IKK inhibitors such as cyclopentenone prostaglandins, arsenite, and antirheumatic gold compounds. Here we show that a mutant IKK beta in which Cys-179 is substituted with alanine had decreased activity when it was expressed in HEK-293 cells, and TNF stimulation did not restore the activity. Phosphorylation of activation loop serines (Ser-177 and Ser-181) which is required for IKK beta activation was reduced in the IKK beta (C179A) mutant. The activity of IKK beta (C179A) was partially recovered when its phosphorylation was enforced by coexpression with mitogen-activated protein kinase kinase kinases (MAPKKK) such as NF-kappa B inducing kinase (NIK) and MAPK/extracellular signal-regulated kinase kinase kinase 1(MEKK1) or when the serine residues were replaced with phospho-mimetic glutamate. The IKK beta (C179A) mutant was normal in dimer formation, while its activity abnormally responded to the change in the concentration of substrate ATP in reaction mixture. Our results suggest that Cys-179 of IKK beta plays a critical role in enzyme activation by promoting phosphorylation of activation-loop serines and interaction with ATP.
Transfection
;
Serine/*metabolism
;
Protein Binding
;
Phosphorylation
;
Mutant Proteins/chemistry
;
MAP Kinase Kinase Kinases/metabolism
;
I-kappa B Kinase/*chemistry
;
Humans
;
Hela Cells
;
Enzyme Activation/*physiology
;
Cysteine/*physiology
;
Cells, Cultured
;
Catalytic Domain
;
Amino Acid Substitution/physiology
;
Adenosine Triphosphate/metabolism

Result Analysis
Print
Save
E-mail